D
Derk J. Bergsma
Researcher at GlaxoSmithKline
Publications - 25
Citations - 9583
Derk J. Bergsma is an academic researcher from GlaxoSmithKline. The author has contributed to research in topics: Receptor & 5-HT5A receptor. The author has an hindex of 19, co-authored 25 publications receiving 9134 citations. Previous affiliations of Derk J. Bergsma include University of Pennsylvania.
Papers
More filters
Journal ArticleDOI
Orexins and Orexin Receptors: A Family of Hypothalamic Neuropeptides and G Protein-Coupled Receptors that Regulate Feeding Behavior
Takeshi Sakurai,Akira Amemiya,Makoto Ishii,Ichiyo Matsuzaki,Richard M. Chemelli,Hirokazu Tanaka,S. Clay Williams,James A. Richardson,Gerald P. Kozlowski,Shelagh Wilson,Jonathan R.S. Arch,Robin E. Buckingham,Andrea C. Haynes,Steven A. Carr,Roland S. Annan,Dean E. McNulty,Wu Schyong Liu,Jonathan A. Terrett,Nabil Elshourbagy,Derk J. Bergsma,Masashi Yanagisawa +20 more
TL;DR: Two novel neuropeptides are identified, both derived from the same precursor by proteolytic processing, that bind and activate two closely related (previously) orphan G protein-coupled receptors in the hypothalamus of rats.
Journal ArticleDOI
AXOR12, a Novel Human G Protein-coupled Receptor, Activated by the Peptide KiSS-1
Alison I. Muir,Larissa Chamberlain,Nabil Elshourbagy,David Michalovich,Darren J. Moore,Amy Calamari,Philip G. Szekeres,Henry M. Sarau,Jon K. Chambers,Paul R. Murdock,Klaudia Steplewski,Usman Shabon,Jane E. Miller,Susan E. Middleton,John G. Darker,Christopher Larminie,Shelagh Wilson,Derk J. Bergsma,Piers C. Emson,Richard L.M. Faull,Karen L. Philpott,David C. Harrison +21 more
TL;DR: High potency agonism was evident from peptides derived from the gene KiSS-1, the expression of which prevents metastasis in melanoma cells, and the nature of the putative cognate ligand for AXOR12 are discussed.
Journal ArticleDOI
Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14
Robert S. Ames,Henry M. Sarau,Johathan K. Chambers,Robert N. Willette,Nambi Aiyar,Anne M. Romanic,Calvert Louden,James J. Foley,Charles F. Sauermelch,Robert W. Coatney,Zhaohui Ao,Jyoti Disa,Stephen Dudley Holmes,Jeffrey M. Stadel,John D. Martin,Wu-Schyong Liu,George I. Glover,Shelagh Wilson,Dean E. McNulty,Catherine E. Ellis,Nabil Elshourbagy,Usman Shabon,John J. Trill,Douglas W. P. Hay,Eliot H. Ohlstein,Derk J. Bergsma,Stephen A. Douglas +26 more
TL;DR: The identification of an orphan human G-protein-coupled receptor homologous to rat GPR14 and expressed predominantly in cardiovascular tissue, which functions as a U-II receptor, the most potent mammalian vasoconstrictor identified so far.
Journal ArticleDOI
A G Protein-coupled Receptor for UDP-glucose
Jon K. Chambers,Macdonald Lynn,Henry M. Sarau,Robert S. Ames,Katie Freeman,James J. Foley,Yuan Zhu,Megan M. McLaughlin,Paul R. Murdock,Mcmillan Lynette Jane,John J. Trill,Ann M. Swift,Nambi Aiyar,Paul H. Taylor,Lisa Vawter,Sajda Naheed,Philip G. Szekeres,Guillaume Hervieu,Claire Scott,Jeanette M. Watson,Andrew J. Murphy,Emir Duzic,Christine Klein,Derk J. Bergsma,Shelagh Wilson,George P. Livi +25 more
TL;DR: It is shown that UDP-glucose, and some closely related molecules, potently activate the orphan G protein-coupled receptor KIAA0001 heterologously expressed in yeast or mammalian cells, suggesting that some sugar-nucleotides may serve important physiological roles as extracellular signaling molecules in addition to their familiar role in intermediary metabolism.
Journal ArticleDOI
Identification, Molecular Cloning, Expression, and Characterization of a Cysteinyl Leukotriene Receptor
Henry M. Sarau,Robert S. Ames,Jon K. Chambers,Catherine E. Ellis,Nabil Elshourbagy,James J. Foley,Dulcie B. Schmidt,Roseanna M. Muccitelli,Owen Jenkins,Paul R. Murdock,Nicole C. Herrity,Wendy S. Halsey,Ganesh M. Sathe,Alison I. Muir,Parvathi Nuthulaganti,George M. Dytko,Peter T. Buckley,Shelagh Wilson,Derk J. Bergsma,Douglas W. P. Hay +19 more
TL;DR: The discovery of this CysLTR receptor, which has characteristics of the purported CysLT(1) receptor subtype, should assist in the elucidation of the pathophysiological roles of the Cys LTs and in the identification of additional receptor subtypes.